Europe’s AI in Healthcare market is poised for significant growth, projected to reach USD 31.72 billion by 2030, driven by regulatory clarity and cloud adoption. As healthcare systems face increasing pressure to enhance outcomes and efficiency, AI technologies are rapidly shifting from pilot programs to essential, compliant deployments.
FOSSA and SCANOSS have partnered to enhance open source compliance by providing snippet-level visibility into AI-generated code, addressing potential intellectual property risks. This collaboration combines advanced code detection techniques with robust license management, enabling teams to identify compliance issues without hindering development speed.
Artificial Intelligence (AI) is revolutionizing Computerized System Validation (CSV) in healthcare and life sciences by enhancing efficiency, reducing human error, and maintaining rigorous standards for patient safety and regulatory compliance.
Europe faces significant challenges in the AI race, having produced only three AI foundation models compared to the US’s 40 and China’s 15. Despite top talent, regulatory burdens and funding gaps hinder Europe’s growth and innovation in AI.
The development of Artificial Intelligence is now inseparably linked with ethical considerations. Prioritizing ethical AI helps prevent discrimination, ensures accountability, and fosters trust among users, making it essential for developers and companies alike.
Indonesia’s Minister of Communication and Digital Application, Meutya V. Hafid, announced that regulating artificial intelligence (AI) is a key priority for President Prabowo Subianto in 2026. The government is preparing two major regulatory frameworks: a Presidential Regulation on the National AI Roadmap and guidelines on AI safety and ethics.
On December 11, 2025, President Trump signed an Executive Order limiting state governments’ powers to regulate artificial intelligence in favor of federal pre-emption, linking compliance with federal funding, and directing agencies to challenge conflicting state regulations, aiming to foster innovation but raising concerns about regulatory and legal risks.
Artificial intelligence accelerates content creation and distribution, raising significant intellectual property risks. These risks affect not only users but also the companies developing and deploying AI tools. Companies must document governance across the AI lifecycle and ensure their marketing and product claims reflect actual functionalities to mitigate secondary liability.
The US Department of Transportation plans to use artificial intelligence to draft safety rules for transportation, raising concerns among staff about potential errors and the implications for public safety. Despite skepticism regarding the reliability of AI, the department aims to expedite the rulemaking process, with an expectation that AI tools will handle a significant portion of the regulatory writing.
In 2025, securities litigation over artificial intelligence claims intensified significantly, with AI-related filings doubling from seven in 2023 to 15 in 2024. This surge reflects increasing market rewards for AI innovation and heightened scrutiny by plaintiffs’ counsel when stock prices fall.
